Source:http://linkedlifedata.com/resource/pubmed/id/14767808
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-2-9
|
pubmed:abstractText |
Highly active antiretroviral therapy (HAART) curtails human immunodeficiency virus type 1 (HIV-1) replication in lymphatic tissues and partially reverses the pathological damage associated with infection, but the genes that mediate these pathological and reparative processes remain largely unknown. To identify these genes, we used microarrays to profile gene expression in serial lymph node biopsy specimens obtained before and after treatment. We discovered approximately 200 treatment-responsive genes, many of them known mediators and moderators of immune activation and defenses, particularly innate defense genes, which, surprisingly, were expressed at all stages of HIV-1 infection. Most of the rest of the treatment-responsive genes we categorized as mediators of trafficking, reformation of active follicles, and tissue repair. We propose a model in which nearly counterbalanced functions of mediators and moderators of immune activation and defenses account for the slow dynamics of HIV-1 infection before treatment. This model suggests that there could be a role for anti-inflammatory agents, alone or in combination with HAART, in treating HIV-1 infection by tipping this balance to mitigate pathology.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/K24 AI 56986,
http://linkedlifedata.com/resource/pubmed/grant/P30 CA 79458,
http://linkedlifedata.com/resource/pubmed/grant/R01 AI 54232,
http://linkedlifedata.com/resource/pubmed/grant/R01 AI 56997,
http://linkedlifedata.com/resource/pubmed/grant/R01 DE 12934,
http://linkedlifedata.com/resource/pubmed/grant/R37 AI 28246
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
189
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
572-82
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:14767808-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:14767808-Anti-HIV Agents,
pubmed-meshheading:14767808-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:14767808-Biopsy,
pubmed-meshheading:14767808-DNA Primers,
pubmed-meshheading:14767808-Genomics,
pubmed-meshheading:14767808-HIV Infections,
pubmed-meshheading:14767808-HIV-1,
pubmed-meshheading:14767808-Lymph Nodes,
pubmed-meshheading:14767808-Lymphoid Tissue,
pubmed-meshheading:14767808-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:14767808-RNA, Viral
|
pubmed:year |
2004
|
pubmed:articleTitle |
Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy.
|
pubmed:affiliation |
Department of Microbiology, Department of Medicine, University of Minnesota Medical School, 420 Delaware Street SE, Minneapolis, MN 55455, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|